RhumbLine Advisers
SWAV

RhumbLine Advisers’s Shockwave Medical, Inc. Common Stock SWAV Stock Holding History

RhumbLine Advisers’s Portfolio SWAV Stock Details SWAV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-106,301
Closed -$34.6M – 4392
2024
Q1 		$34.6M Sell
106,301
-3,452
-3% -$847K 0.03% 450
2023
Q4 		$20.9M Sell
109,753
-3,352
-3% -$634K 0.02% 666
2023
Q3 		$22.5M Sell
113,105
-379
-0.3% -$89.6K 0.03% 570
2023
Q2 		$32.4M Buy
113,484
+16
+0% +$4.44K 0.04% 432
2023
Q1 		$24.6M Sell
113,468
-286
-0.3% -$55.7K 0.03% 514
2022
Q4 		$23.4M Buy
113,754
+3,567
+3% +$902K 0.03% 517
2022
Q3 		$30.6M Buy
110,187
+4,361
+4% +$1.11M 0.05% 371
2022
Q2 		$20.2M Buy
105,826
+70,385
+199% +$12.4M 0.03% 526
2022
Q1 		$7.35M Buy
35,441
+526
+2% +$86.7K 0.01% 1103
2021
Q4 		$6.23M Sell
34,915
-779
-2% -$154K 0.01% 1240
2021
Q3 		$7.35M Buy
35,694
+1,219
+4% +$239K 0.01% 1124
2021
Q2 		$6.54M Buy
34,475
+3,641
+12% +$596K 0.01% 1280
2021
Q1 		$4.02M Sell
30,834
-4,143
-12% -$497K 0.01% 1531
2020
Q4 		$3.63M Buy
34,977
+2,823
+9% +$245K 0.01% 1544
2020
Q3 		$2.44M Sell
32,154
-6,660
-17% -$378K ﹤0.01% 1562
2020
Q2 		$1.84M Buy
38,814
+6,374
+20% +$263K ﹤0.01% 1774
2020
Q1 		$1.08M Buy
32,440
+3,258
+11% +$129K ﹤0.01% 1846
2019
Q4 		$1.28M Buy
+29,182
New +$1.08M ﹤0.01% 1973
2019
Q3 		– Sell
-6,575
Closed -$375K – 2962
2019
Q2 		$375K Buy
+6,575
New +$319K ﹤0.01% 2490

Other funds holding SWAV

SA
Sanctuary Advisors Indianapolis, Indiana $18.5B AUM 23.32% 1-Year Est. Return
UWS
Unique Wealth Strategies Burr Ridge, Illinois $275M AUM 29.58% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
MG
Mather Group Chicago, Illinois $10B AUM 15.14% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

RhumbLine Advisers's SWAV Position: Q2 2024 in Review

RhumbLine Advisers sold out of Shockwave Medical, Inc. Common Stock (SWAV) in Q2 2024, closing a stake of 106,301 shares — an estimated $34.6M sold.

RhumbLine Advisers first reported a position in SWAV in Q2 2019 and held it in 19 quarters. The position peaked at $34.6M in Q1 2024. 7 funds tracked by Wall St. Rank hold SWAV as of Q2 2024.

  • RhumbLine Advisers reported no remaining Shockwave Medical, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • RhumbLine Advisers sold 106,301 Shockwave Medical, Inc. Common Stock shares in Q2 2024, an estimated $34.6M.
  • RhumbLine Advisers first reported a position in Shockwave Medical, Inc. Common Stock in Q2 2019 and held it in 19 quarters.
  • RhumbLine Advisers's Shockwave Medical, Inc. Common Stock position peaked at $34.6M in Q1 2024.
  • 7 funds tracked by Wall St. Rank held Shockwave Medical, Inc. Common Stock as of Q2 2024.

Based on RhumbLine Advisers's 13F filing for Q2 2024, filed 1 Aug 2024.